Caldwell County Hospital, INC
Caldwell County Hospital, INC was paid $16.36M by Medicaid between Jan 2018 and Dec 2024, across 123 billing codes. Its largest line is 74176, Computed tomography, abdomen and pelvis; without contrast material — 17% of everything it billed.
33Billing provider infoCALDWELL COUNTY HOSPITAL, INC
PRINCETON, KY 42445
PRINCETON, KY 42445
33aNPI1780688333assigned 06/10/2005
33bProvider typeSpeech-Language Pathologist
28Total paid$16.36M
24GClaims219,275
24DCodes billed123
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Speech-Language Pathologist providers in Kentucky
Rank by total paid#4 of 52
Median peer was paid$82K
This provider vs. median199×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,782 | $1.52M | |
| 2019 | 25,461 | $2.13M | |
| 2020 | 25,301 | $2.48M | |
| 2021 | 36,369 | $2.77M | |
| 2022 | 40,995 | $2.49M | |
| 2023 | 38,237 | $2.76M | |
| 2024incomplete | 29,130 | $2.21M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 17% | 2,659 | 2,252 | $2.79M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 8,149 | 7,097 | $2.12M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 5,213 | 4,399 | $1.98M |
| 70450 | Computed tomography, head or brain; without contrast material | 6.4% | 2,074 | 1,757 | $1.04M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.3% | 7,179 | 6,109 | $1.03M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.3% | 2,485 | 1,867 | $1.02M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.2% | 298 | 273 | $519K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.4% | 6,025 | 4,159 | $398K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.0% | 9,297 | 1,673 | $333K |
| 80053 | Comprehensive metabolic panel | 1.9% | 13,250 | 10,631 | $314K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.9% | 1,880 | 1,423 | $314K |
| 71046 | Radiologic examination, chest; 2 views | 1.6% | 3,020 | 2,564 | $269K |
111 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.6% | 3,124 | $267K |
| 36415 | Collection of venous blood by venipuncture | 1.4% | 37,801 | $230K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 2,253 | $228K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.2% | 4,394 | $200K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 1,732 | $180K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 11,233 | $180K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.0% | 226 | $169K |
| 87428 | <1% | 3,067 | $163K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,645 | $159K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 975 | $153K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,568 | $147K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,488 | $132K |
| 71250 | <1% | 209 | $105K | |
| 80061 | Lipid panel | <1% | 3,930 | $97K |
| 80306 | <1% | 2,136 | $95K | |
| 73630 | <1% | 871 | $92K | |
| 84484 | <1% | 2,673 | $92K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,528 | $85K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 575 | $83K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 2,280 | $82K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,159 | $74K |
| 72110 | <1% | 428 | $71K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 880 | $69K |
| 81001 | <1% | 4,970 | $64K | |
| 83874 | <1% | 1,759 | $62K | |
| 82553 | <1% | 1,719 | $56K | |
| 73130 | <1% | 535 | $53K | |
| 73562 | <1% | 566 | $52K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,411 | $44K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,722 | $40K |
| 73030 | <1% | 401 | $37K | |
| 85379 | <1% | 858 | $36K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 890 | $36K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,455 | $35K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 343 | $35K |
| 83690 | <1% | 2,405 | $34K | |
| 81025 | <1% | 1,743 | $30K | |
| 73610 | <1% | 266 | $27K | |
| 73110 | <1% | 237 | $25K | |
| 87070 | <1% | 1,314 | $24K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,517 | $24K |
| 82150 | <1% | 2,163 | $23K | |
| 85027 | <1% | 1,978 | $22K | |
| 87430 | <1% | 1,249 | $21K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 636 | $19K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 323 | $19K |
| 83880 | <1% | 382 | $19K | |
| 80178 | <1% | 1,001 | $18K | |
| 86756 | <1% | 694 | $18K | |
| J3490 | Unclassified drugs | <1% | 2,144 | $16K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 97 | $15K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 595 | $13K |
| 81003 | <1% | 1,384 | $11K | |
| 82607 | <1% | 493 | $9K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 1,490 | $8K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 24 | $7K |
| 0012A | <1% | 247 | $7K | |
| G0307 | Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) | <1% | 428 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 735 | $7K |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 244 | $5K |
| 72050 | <1% | 26 | $5K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 8,735 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 134 | $5K |
| 84480 | <1% | 177 | $4K | |
| 84436 | <1% | 445 | $4K | |
| 0011A | <1% | 240 | $4K | |
| 93356 | <1% | 80 | $4K | |
| 83550 | <1% | 371 | $4K | |
| 83735 | <1% | 342 | $4K | |
| 84439 | <1% | 268 | $4K | |
| 87077 | <1% | 382 | $4K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $4K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 411 | $3K |
| 83540 | <1% | 385 | $3K | |
| 85610 | <1% | 268 | $3K | |
| 80164 | <1% | 214 | $3K | |
| 80050 | General health panel | <1% | 72 | $3K |
| 87040 | <1% | 68 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 290 | $2K |
| 74022 | <1% | 13 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 95 | $2K |
| 80320 | <1% | 76 | $2K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 111 | $2K |
| 80305 | <1% | 171 | $2K | |
| 73564 | <1% | 12 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 84 | $1K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 53 | $1K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 6,775 | $864.83 |
| 82803 | <1% | 17 | $825.05 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 28 | $727.63 |
| 84703 | <1% | 41 | $699.32 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 32 | $690.43 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 39 | $626.92 |
| 90686 | <1% | 19 | $584.22 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 82 | $422.75 |
| 36600 | <1% | 17 | $397.76 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 30 | $379.10 |
| 83986 | <1% | 33 | $337.99 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 73 | $304.38 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 27 | $256.91 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 26 | $203.16 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 14 | $190.78 |
| 83605 | <1% | 12 | $177.67 | |
| 87186 | <1% | 14 | $157.87 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 55 | $107.60 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 14 | $93.89 |
| 82570 | <1% | 14 | $83.93 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 12 | $53.81 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 39 | $30.42 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 13 | $8.24 |
| 91301 | <1% | 192 | $0.79 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARPENTER, TERESA (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Caldwell County Hospital INC | Princeton, KY | $548K |
| Caldwell County Hospital, INC | Princeton, KY | $450K |
| Caldwell County Hospital, INC | Princeton, KY | $252K |
| Caldwell County Hospital INC | Fredonia, KY | $72K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.